Israeli generic drug developer Teva Pharmaceutical Industries Ltd. said Friday a court ruled against it in a patent dispute with Eisai Co's over the heartburn drug Aciphex. The US District Court for the Southern District of New York upheld Eisai's patent on the drug, Teva said. Eisai sued Israel-based Teva in 2003 over its plans for a generic version of Aciphex. Teva had received Food and Drug Administration approval for the generic version.

Posted by GEN-ERIC at 12:05:45 am into the following categories: In The News

---

http://gen-eric.com/patents/htsrv/trackback.php/1156

Name:

Email: (not displayed on this site)

Site/Url:

Comment text:

Allowed XHTML tags: <p, ul, ol, li, dl, dt, dd, address, blockquote, ins, del, a, span, bdo, br, em, strong, dfn, code, samp, kdb, var, cite, abbr, acronym, q, sub, sup, tt, i, b, big, small>

URLs, email, AIM and ICQs will be converted automatically.

Options:
Auto-BR (Line breaks become <br />)
Remember me (Set cookies for name, email & url)